FSNUF Stock News Fresenius Ag [Dem 50 (FSNUF) 147.5975 07/26/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fresenius Ag [Dem 50 (FSNUF) 147.5975 $FSNUF

Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding

Global Burns Clinical Trials Report - H2 2013 Edition
M2 - Fri Jan 10, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4vpq56/burns_global) has announced the addition of the "Burns Global Clinical Trials Review, H2, 2013" report to their offering. This report provides elemental information and data relating to the clinical trials on Burns. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Burns. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Burns Therapeutics Clinical Trials - MediWound Ltd. - Fibrocell Science, Inc. - Bayer AG - Plethora Solutions Holdings plc - Kuros Biosurgery AG - Klinikum St. Georg gGmbH - HealOr Ltd. - Fresenius SE & Co. KGaA - Birken AG - Baxter International Inc. Clinical Trial Overview of Top Institutes / Government - The University of Texas Medical Branch at Galveston - Massachusetts General Hospital - Shriners Hospitals for Children - U.S. Army Institute of Surgical Research - Shiraz University of Medical Sciences - National Institute of General Medical Sciences - Tehran University of Medical Sciences - Association of Dutch Burn Centres - Third Military Medical University - Johns Hopkins University For more information visit http://www.researchandmarkets.com/research/4v...rns_global

Malnutrition Global Clinical Trials Review, H2 2013: Profiles Players Such as Danone Research B.V., Royal Numico N.V. and Helen Keller International
M2 - Fri Jan 10, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/38jm2d/malnutrition) has announced the addition of the "Malnutrition Global Clinical Trials Review, H2, 2013" report to their offering. The clinical trial report, Malnutrition Global Clinical Trials Review, H2, 2013" provides data on the Malnutrition clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malnutrition. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malnutrition. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Companies Mentioned: -Abbott Laboratories -Aga Khan University -Baxter International Inc. -Baylor College of Medicine -Copenhagen University Hospital at Herlev -Cornell University -Danone Research B.V. -DaVita HealthCare Partners Inc. -Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH -Epicentre Biotechnologies -Fresenius SE & Co. KGaA -Helen Keller International -Royal Numico N.V. -University Hospital Inselspital, Berne -University of California, Davis -University of Oxford -University of Tampere -Washington University School of Medicine For more information visit http://www.researchandmarkets.com/research/38...lnutrition About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Intravenous Solutions (Parenteral Nutrition) - 2013 Global Strategic Business Report Features Giants such as Actavis, Inc and Hospira, Inc.
M2 - Mon Sep 02, 12:17PM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvnnn3/intravenous#summary) has announced the addition of the "Intravenous Solutions (Parenteral Nutrition) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 30 companies including many key and niche players such as: - Actavis Inc. - B. Braun Melsungen AG - Baxter International Inc. - Claris Lifesciences Ltd. - Fresenius SE & Co. KGaA - Fresenius Kabi AG - Sino-Swed Pharmaceutical Corp. Ltd. - Hospira Inc. - Otsuka Pharmaceutical Factory Inc. - Marck Biosciences Ltd. - Sichuan Kelun Pharmaceutical Co. Ltd. - Terumo Corporation - The Galenica Group - Vifor Pharma. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: Normal 0 false false false MicrosoftInternetExplorer4 I. Introduction, Methodology & Product Definitions Ii. Executive Summary 1. Industry Overview 2. Intravenous Solutions 3. Parenteral Nutrition - An Overview 4. Product Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective Iii. Market Iv. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/jv...us#summary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 170

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 115

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 88

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 10

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 23

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Unishippers Climbs 18 Slots on 32.4% Sales Growth Run

Updated Category News Views 122

Thirty new franchise units can move the needle fast Unishippers did not inch its way up the Franchise Times Top 400; it put up a number that deserves a hard look. Sales rose 32.4% in 2025, the company added 30 franchise units, and the result was an 18-place jump to No. 81 on the 2026 ranking. In the shipping category, it was named the sales-growth leader. For a business...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 118

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 17

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 160

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Inhabit Puts AI Across Its Property Management Stack

Updated Category News Views 72

Property managers do not need another shiny chatbot; they need fewer dropped leads, fewer invoice-entry mistakes and less staff time burned chasing routine answers. That is the sensible hook in Inhabit's OPTECH 2026 announcement. The company is spreading AI, integrations and scalability work across ResMan, Anyone Home, ePremium, Nationwide Compliant and several adjacent...

Continue Reading

Top 5 Most Recently Viewed Articles

Anivive's Lab Expansion: Driving Innovation in Veterinary Diagnostics

Updated Category News Views 130

Expanding Horizons in Veterinary Diagnostics Anivive is embarking on an exciting journey as it expands its state-of-the-art laboratory, a move that reflects the soaring demand for its specialized pathology services. This enhancement comes in response to the growing interest in veterinary diagnostics, particularly through its subsidiary, Vidium, known for its leadership in...

Continue Reading
Aurora Chen Joins PBGH as Vice President to Lead Advisory Services

Updated Category News Views 239

Aurora Chen Joins PBGH as Vice President of Advisory Services PBGH, a notable nonprofit coalition, has proudly announced the appointment of Aurora Chen as its Vice President of Advisory Services. Bringing a wealth of experience in the health care and employee benefits sector, Chen is set to lead efforts that expand and enhance the advisory services offered by PBGH. This...

Continue Reading
What Are the Pros and Cons of Using a Financial Planner?

Updated Category Personal Finance Views 654

Are you considering enlisting the help of a financial planner and aren’t sure if it's the right choice for you? Then you need to know about their pros and cons! Financial planners play a vital role in offering you support and guidance with tailor-made plans that help you meet your savings, retirement, or investment goals. We have outlined the pros and cons of a...

Continue Reading
Angel Oak Financial Strategies Trust Announces March 2025 Dividend

Updated Category News Views 113

Introduction to Angel Oak Financial Strategies Income Term Trust Angel Oak Financial Strategies Income Term Trust (FINS) has declared a monthly distribution that investors eagerly anticipate. The closed-end fund listed on the New York Stock Exchange is making headlines as it announces a distribution of $0.109 per share for March. Understanding the mechanics behind such...

Continue Reading
Investors Eye Value Stocks as Federal Reserve Makes Moves

Updated Category News Views 81

Exploring Value Stocks Amid Federal Adjustments Bank of America has underscored three key sectors that stand to gain from the Federal Reserve's unique dual approach of cutting interest rates while profits rise in corporate sectors. This 'rare double whammy of stimulus' could present a significant opportunity for savvy investors keen on value stocks. Key Sector Highlights...

Continue Reading